A protective monoclonal antibody targets a site of vulnerability on the surface of Rift Valley fever virus (Cell Reports, 2018)

(untitled) - Allen, ER; Krumm, SA; Raghwani, J; Halldorsson, S; Elliott, A; Graham, VA; Koudriakova, E; Harlos, K; Wright, D; Warimwe, GM; Brennan, B; Huiskonen, JT; et al.